Featured MM&M Awards 2012 Sponsor



Paul Werth Associates is an independent, full-service communications firm that helps clients build brands, enhance reputations, and shape public policies. For five decades, Werth has been guiding clients navigate the changing tides of economic, social and marketing conditions. Our affiliation with the MSLGROUP enables us to offer clients global reach.

The Agency Gallery


SUBSCRIBE TO MM&M


MM&M offers the most relevant news, analysis, opinion, feature stories and special reports to nearly 15,000 marketing executives at pharma companies, agencies and in healthcare media. Click here to subscribe.

THE INTERACTIVE GUIDE


Click here to read the MM&M 2013 Mobile Guide, with the latest trends, data, insights and expert advice on the challenges and opportunities of using mobile to reach healthcare professionals and consumers

2011/12 Pharmaceutical Marketers Directory


NOW FULLY
SEARCHABLE ONLINE
UPDATED MONTHLY @ ThePMD.com
Over 6,000 new names, and 20,000 business connections. From the industry's trusted resource for over 34 years. Now find what you need even quicker and easier with the searchable online edition.

Get connected today and order your personal copy and free online access!

The MM&M News Brief provides news and features delivered direct to your inbox. To access the full text, simply click the headline.

Latest News

Bydureon catching on among endos but low profits expected, Amylin says

Amylin said weekly diabetes shot Bydureon, launched in February, is gaining market share among influential physicians but expects the med's profit margins to be low for some time.
 

2Million2Many campaign flags bone fracture, osteoporosis link

The National Bone Health Alliance and inVentiv shop GSW Worldwide are launching 2Million2Many, a national education campaign designed to raise awareness of the connection between osteoporosis and broken bones.
 

In Brief

Company news: BMS, Shire, Walgreen

Better than expected US sales of Plavix helped Bristol-Myers Squibb power through the first quarter with a 5% revenue gain over the first quarter of 2011, while Shire announced quarter product sales of $1.1 billion for the quarter, a 24% increase over the year-ago period. A Walgreen Co. study shows that discount prescription programs and pharmacists can have a major impact on keeping patients on their medication regimens.
 

 
IncreaseRx is a self-funding, gain-share, multi-channel solution that integrates digital and traditional marketing tactics into a comprehensive program designed to increase targeted HCP access, maximize market share and generate incremental revenue.

To learn more about our performance-based business model that assumes all promotional costs, click here or call 828-255-0012, ext 105.


What our audiences care about: women's health, diabetes, digestive health, mental health, and more. What you care about: reaching them with your brand messages. How the two of you connect: That's what we care about. We're eHealthcare Solutions. Connect with us to learn more.



Regional Marketing is An Essential Part of the Mix for Marketing and Sales Executives Regional marketing is now an essential element of the marketing mix, resulting in increased return on investment for many pharmaceutical brands. Please download Healthcare in a Whole New Light to understand the value of regional marketing or learn how to implement it for your brand.

Destination vs. Distribution Model of eSampling

Join featured industry leaders from Pfizer and Physicians Interactive as we discuss the astounding growth of eSampling and how pharma brands can best leverage these opportunities. Discuss strategies and challenges of reaching healthcare providers with drug samples and how to effectively integrate digital or mobile sampling.

Click here to join the Webinar May 1, 2012 at 1:00 pm EST.

LATEST FEATURES

DTC: Beyond the Blockbuster

The mass-market, TV-and-print DTC formula is going the way of the vanishing primary care blockbusters it was designed to boost as new media and niche products fill the breach, Matthew Arnold reports
 

MM&M Therapeutic Focus: Metabolic

With the FDA weighing a new Rx diet therapy, we review the anti-obesity sector. Noah Pines on the hype and hurdles for Vivus's Qnexa and its would-be competitors, and the diabetes controversy
 

Orphan Drugs: Small is the New Big

Orphan drug approvals are up, thanks to marketing exclusivity and development incentives. Deborah Weinstein charts the industry's drive to think small, highlighting tactics for drawing attention
 

Journal Ad Review 2011: On a Tear

Medical/surgical journal advertising grew in 2011, the second consecutive year it's been in the black. Marc Iskowitz on which categories and brands attracted the most advertising dollars
 

Headliner: Easing NEJM into its third century

Tom Easley, publisher, managing director of The New England Journal of Medicine
 



Advertise
For details on how to advertise in MM&M News Brief, please email Doreen Gates

Unsubscribe
To unsubscribe from the MM&M News Brief click here.
To manage your entire MM&M profile login to your account.

You are subscribed as: %%EMAIL%%

To contact Haymarket Media for general questions or unsubscribe problems, please reply to this email.

All MM&M newsletters are sent from the domain "email.mmm-online.com". When configuring e-mail or spam
filter rules, please use this domain name.

Medical Marketing & Media Magazine
114 W. 26th Street 4th Floor
New York N.Y. 10001
Phone: (646) 638-6000
Fax: (646) 638-6150
http://www.mmm-online.com/

© 2013 Haymarket Media Inc.